openPR Logo
Press release

Drug Screening Market Growth Rate, Future Trends and Challenges, Major Drivers and Opportunities to 2025 | Alfa Scientific Desings, Dragewerk, Labcorp, Lifeloc, MPD Inc., Omega Laboratories

08-14-2019 08:57 AM CET | IT, New Media & Software

Press release from: Premium Market Insights

Premium Market Insights

Premium Market Insights

Global Drug Screening Market valued approximately USD 4.9 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2017-2025. Driven by increasing consumption of drug & alcohol, stringent regulations mandating drug and alcohol testing the global drug increasing market is witnessing various opportunities over the forecast period. Furthermore, government funding, and novel product development are anticipated to compel positive growth in the market.

Top Companies Covered in this Report:
Alfa Scientific Desings, Dragewerk, Labcorp, Lifeloc, MPD Inc., Omega Laboratories, Orasure, Premier Biotech, Psychemedics, Quest Diagonstics, Roche, Shimadzu, Siemens Healthineers, Thermo Fisher Scientific

Get sample copy of “Drug Screening Market” at: https://www.premiummarketinsights.com/sample/BRC00017246

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drug Screening market in these regions.

 The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Drug Screening market based on product, source and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, AsiaPacific (APAC), Middle East and Africa (MEA) and South & Central America.

Have any query? Enquire about report at: https://www.premiummarketinsights.com/discount/BRC00017246

Fundamentals of Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type       
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Drug Screening Market Size
2.2 Drug Screening Growth Trends by Regions
2.3 Industry Trends

3 Market Share by Key Players
3.1 Drug Screening Market Size by Manufacturers
3.2 Drug Screening Key Players Head office and Area Served
3.3 Key Players Drug Screening Product/Solution/Service
3.4 Date of Enter into Drug Screening Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Drug Screening Sales by Product
4.2 Global Drug Screening Revenue by Product
4.3 Drug Screening Price by Product

5 Breakdown Data by End User                                     
5.1 Overview
5.2 Global Drug Screening Breakdown Data by End User

Get Complete Report at: https://www.premiummarketinsights.com/buy/BRC00017246

Contact Us:                                          
Call: +912067274191
Email: sales@premiummarketinsights.com

About Premiummarketinsights:

Premiummarketinsights.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Screening Market Growth Rate, Future Trends and Challenges, Major Drivers and Opportunities to 2025 | Alfa Scientific Desings, Dragewerk, Labcorp, Lifeloc, MPD Inc., Omega Laboratories here

News-ID: 1822110 • Views:

More Releases from Premium Market Insights

Next Generation Sequencing Market Analysis and Clinical Aspect Review till 2025
Next Generation Sequencing Market Analysis and Clinical Aspect Review till 2025
Next-generation sequencing (NGS), is also known as high-throughput sequencing. NGS enables rapid sequencing of the base pairs in DNA or RNA samples. NGS is driving discovery and enabling the future of personalized medicine, genetic diseases, and clinical diagnostics. However, in this research study, the products of NGS have been classified into three broad segments consumables, services, and platforms. The growth of the Next-generation sequencing in the healthcare market is attributed
Pediatric MRI Market Evolving Technology and Growth Outlook 2022 to 2028
Pediatric MRI Market Evolving Technology and Growth Outlook 2022 to 2028
Pediatric MRI uses a powerful magnetic field, radio waves, and a computer to produce detailed images of the child's body. MRI is used to diagnose or monitor treatment for a variety of conditions within the chest, brain, abdomen, pelvis, and extremities. It is also used for imaging the joints and bones to diagnose sports-related injuries or to detect the presence of a tumor or infection in a joint. Click Here to
Laboratory Information Management Systems Market Developments, Competitive Analysis, and Forecasts till 202
Laboratory Information Management Systems Market Developments, Competitive Analy …
A laboratory information management system (LIMS), also known as a laboratory information system (LIS) or laboratory management system (LMS), is a software-based solution that supports modern laboratory operations. Key features of LIMS include workflow management as well as data tracking and processing. Its flexible architecture and data exchange interfaces support its use in regulated clinical environments. The features and uses of LIMS have evolved over the years from simple sample
Public Key Infrastructure Market Business Opportunities, Current Trends, Challenges and Forecast 2022-2030
Public Key Infrastructure Market Business Opportunities, Current Trends, Challen …
"The public key infrastructure market was valued at US$ 3,268.10 million in 2022 and is expected to reach US$ 11,553.84 million by 2030; it is estimated to record a CAGR of 17.1% from 2022 to 2030." According to The Premium Market Insights "Public Key Infrastructure Market" report, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Public Key Infrastructure Market

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug